Carmen Bozic insider trades

Open-market stock purchases and sales by Carmen Bozic, EVP and CMO at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Feb 5, 2020.

Recent trades

DateStockTradeValue
Jun 26, 2026VRTX Vertex Pharmaceuticals Inc / MASold$288K
Jun 18, 2026VRTX Vertex Pharmaceuticals Inc / MASold$471K
Jun 15, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.8M
Jun 5, 2026VRTX Vertex Pharmaceuticals Inc / MASold$785K
May 29, 2026VRTX Vertex Pharmaceuticals Inc / MASold$888K
May 15, 2026VRTX Vertex Pharmaceuticals Inc / MASold$614K
May 12, 2026VRTX Vertex Pharmaceuticals Inc / MASold$3.1M
Mar 27, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.1M
Mar 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.1M
Feb 27, 2026VRTX Vertex Pharmaceuticals Inc / MASold$1.1M
Feb 24, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$705K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$925K
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1.9M
Feb 10, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1M
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 22 sales, last Jun 26, 2026

Get free alerts when Carmen Bozic files a new trade →